VR Logo

Sharon Bio Medicine: Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2021


SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2021 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Unaudited Financial Results of the Company for the quarter and half year ended September 30 20121 along with the Limited Review Report of the Auditors thereon will be considered and approved on Wednesday November 03 2021 at the corporate office of the Company.

As per the Companys code of conduct to regulate monitor and report trading in securities of the Company the trading window for dealing in the securities of the Company was closed from October 1 2021 and will open Forty Eight (48) hours after the declaration of said financial results for the quarter and half year ended September 30 2021.

This is for your information and record.

Click here to view PDF